STAT Plus: Mass. Gov. Charlie Baker’s plan to curb drug prices strains his relationship with biotechs
Massachusetts’ booming biotech industry has long enjoyed a tight — some would say coddling — relationship with lawmakers on Beacon Hill. The state has invested hundreds of millions of taxpayer dollars to help life sciences companies grow.
Suddenly, the relationship is more complicated.
Continue to STAT Plus to read the full story…
